News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
143 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32181)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Business
Neurodyn Appoints Anthony J. Giovinazzo as Director and Executive Chairman
Neurodyn announce the appointment of Anthony Giovinazzo as a director and Executive Chairman of the Company.
December 19, 2017
·
2 min read
Rucaparib MAA for the Ovarian Cancer Treatment Indication Referred by CHMP to Scientific Advisory Group on Oncology for Review Expected in February 2018
The exact date for the SAG meeting has not yet been set but we expect it to take place in early February 2018.
December 19, 2017
·
6 min read
Genetown
Regenacy Pharmaceuticals to Present a Corporate Update at the 10th Annual Biotech Showcase
Regenacy announced today that Simon S. Jones, Ph.D., President and Chief Executive Officer of Regenacy, is scheduled to present a corporate update at the 10th Annual Biotech Showcase.
December 19, 2017
·
4 min read
Drug Development
Regulus Announces First-in-Human Dosing for Phase I Study of RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease
RGLS4326 is being studied in a Phase I randomized, double-blind, placebo-controlled, single ascending dose study designed to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of RGLS4326 administered subcutaneously in healthy volunteers.
December 19, 2017
·
4 min read
Business
Medtronic Exec Jumps Ship to Become Zimmer Biomet CEO
Zimmer Biomet today announced that Bryan C. Hanson has been appointed President and CEO and a member of the Board of Directors, effective today.
December 19, 2017
·
5 min read
Deals
Impax Announces Sale of Taiwan Manufacturing Facility
This sale supports Impax’s operational and cost improvement plans to streamline operations and reduce costs.
December 19, 2017
·
7 min read
Pharm Country
Ortho Clinical Diagnostics Release: A New & Novel Method for the Measurement of Alanine Aminotransferase (ALT) From Ortho Clinical Diagnostics is Now Available
ALT is used in the diagnosis and treatment of certain liver diseases as well as heart diseases.
December 19, 2017
·
3 min read
Pharm Country
The Michael J. Fox Foundation Release: Protein Levels in Spinal Fluid Correlate to Posture and Gait Difficulty in Parkinson’s Disease
This analysis points to associations that could inform subject selection for clinical trials, speeding testing of symptomatic and disease-modifying therapies.
December 19, 2017
·
3 min read
Biotech Bay
Arena Solutions’ New Product Innovations Meet Customer Challenges in Highly Competitive Markets
Throughout 2017, Arena continued to innovate with significant enhancements to PLM processes and compliance in QMS, while significantly increasing capabilities in ALM.
December 19, 2017
·
2 min read
Business
Bristol-Myers Squibb to Announce Results for Fourth Quarter 2017 on February 5th
During a conference call at 8:00 a.m. ET on February 5th company executives will review financial information and will address inquiries from investors and analysts.
December 19, 2017
·
1 min read
Previous
3 of 15
Next